Renal Tumor Ablation Via the Liver Is Safe, Effective
In a small study, researchers show that ultrasound-guided transhepatic radiofrequency ablation is technically feasible.
In a small study, researchers show that ultrasound-guided transhepatic radiofrequency ablation is technically feasible.
Smoking exposure adversely impacts cancer-specific survival and increases the risk of death from another cause in patients with renal cell carcinoma.
Researchers find a 23% increased risk of death among patients who received a transfusion during surgery or post-operative hospitalization.
Expressive writing may improve cancer-related symptoms and physical functioning in renal cell carcinoma.
The International Metastatic Renal Cell Carcinoma Database Consortium model is predictive of patient survival after targeted therapy for mRCC.
Patients with clear cell RCC and the inherited exonic MET rs11762213 had a worse clinical outcome.
Use of ASIs such as lisinopril, captopril, and losartan significantly improved median OS in patients with mRCC compared with ASI non-users.
Pazopanib was clinically active and well tolerated as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma.
This slideshow reviews drug information for VOTRIENT® (pazopanib) for renal cell carcinoma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 6: Use in Specific PopulationsSlide 8: Clinical PharmacologySlide 12: Warnings and PrecautionsSlide 19: Clinical Safety and EfficacySlide 23: Drug Storage and Supply
Active smoking shortens progression-free and overall survival, study finds.